Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	ATP6V1B2 KIF23 DDX31 MYL6 IPO8 DHX40 NLRP1 YTHDC2 CLPX ATP10D DQX1 SHOC1 MACF1 MTREX ATP2A3	7.76e-05	614	153	15	GO:0140657
GeneOntologyMolecularFunction	ATP hydrolysis activity	KIF23 DDX31 DHX40 NLRP1 YTHDC2 CLPX ATP10D DQX1 SHOC1 MACF1 MTREX ATP2A3	1.55e-04	441	153	12	GO:0016887
GeneOntologyMolecularFunction	peptidase regulator activity	TANK NLRP1 CLPX USP14 SERPINB12 A2ML1 ATP2A3 SORL1 SPINK5	1.68e-04	257	153	9	GO:0061134
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	IFT27 KIF23 DDX31 CRACR2A DHX40 NLRP1 YTHDC2 CLPX ATP10D GTPBP2 DQX1 SHOC1 RAB2B MACF1 MTREX ATP2A3	3.07e-04	775	153	16	GO:0017111
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR1 RYR3	3.46e-04	4	153	2	GO:0005219
GeneOntologyMolecularFunction	pyrophosphatase activity	IFT27 KIF23 DDX31 CRACR2A DHX40 NLRP1 YTHDC2 CLPX ATP10D GTPBP2 DQX1 SHOC1 RAB2B MACF1 MTREX ATP2A3	7.26e-04	839	153	16	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	IFT27 KIF23 DDX31 CRACR2A DHX40 NLRP1 YTHDC2 CLPX ATP10D GTPBP2 DQX1 SHOC1 RAB2B MACF1 MTREX ATP2A3	7.36e-04	840	153	16	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	IFT27 KIF23 DDX31 CRACR2A DHX40 NLRP1 YTHDC2 CLPX ATP10D GTPBP2 DQX1 SHOC1 RAB2B MACF1 MTREX ATP2A3	7.36e-04	840	153	16	GO:0016818
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR1 RYR3	8.57e-04	6	153	2	GO:0048763
GeneOntologyMolecularFunction	protein tyrosine kinase activity	JAK1 TYRO3 PTK2B PRKCD MERTK MAP2K5	8.89e-04	145	153	6	GO:0004713
GeneOntologyCellularComponent	centralspindlin complex	KIF23 ECT2	1.55e-04	3	151	2	GO:0097149
GeneOntologyCellularComponent	sarcoplasmic reticulum membrane	KLHL41 RYR1 RYR3 ATP2A3	3.10e-04	45	151	4	GO:0033017
GeneOntologyCellularComponent	perinuclear region of cytoplasm	GC YTHDC2 RYR1 ADD1 RYR3 CASK PTK2B FAT1 SBF1 UBR5 ATXN2 PIK3CA VPS35 TENM1 PRKCD SORL1 SPINK5	4.29e-04	934	151	17	GO:0048471
GeneOntologyCellularComponent	sarcoplasmic reticulum	ANK3 KLHL41 RYR1 RYR3 ATP2A3	4.45e-04	88	151	5	GO:0016529
Domain	ARM-type_fold	MON2 IPO8 XPO1 RYR3 PPP4R3B THADA PIK3CA MTOR NOM1 VPS35 INTS4 WDFY3 GCN1	4.19e-06	339	152	13	IPR016024
Domain	ARM-like	MON2 IPO8 RIPOR3 DAXX XPO1 PPP4R3B MTOR INTS4 WDFY3 GCN1	7.48e-05	270	152	10	IPR011989
Domain	Ryanodine_rcpt	RYR1 RYR3	1.96e-04	3	152	2	IPR003032
Domain	Ryanrecept_TM4-6	RYR1 RYR3	1.96e-04	3	152	2	IPR009460
Domain	RyR	RYR1 RYR3	1.96e-04	3	152	2	PF02026
Domain	RR_TM4-6	RYR1 RYR3	1.96e-04	3	152	2	PF06459
Domain	Ryan_recept	RYR1 RYR3	1.96e-04	3	152	2	IPR013333
Domain	DUF1605	DHX40 YTHDC2 DQX1	3.30e-04	17	152	3	IPR011709
Domain	OB_NTP_bind	DHX40 YTHDC2 DQX1	3.30e-04	17	152	3	PF07717
Domain	ALBUMIN	GC ALB	3.91e-04	4	152	2	SM00103
Domain	Serum_albumin_N	GC ALB	3.91e-04	4	152	2	IPR014760
Domain	Serum_albumin_CS	GC ALB	3.91e-04	4	152	2	IPR020857
Domain	ALBUMIN_2	GC ALB	3.91e-04	4	152	2	PS51438
Domain	PTCB-BRCT	MCPH1 ECT2	3.91e-04	4	152	2	PF12738
Domain	ALBUMIN_1	GC ALB	3.91e-04	4	152	2	PS00212
Domain	Serum_albumin	GC ALB	3.91e-04	4	152	2	PF00273
Domain	HA2	DHX40 YTHDC2 DQX1	3.94e-04	18	152	3	SM00847
Domain	HA2	DHX40 YTHDC2 DQX1	3.94e-04	18	152	3	PF04408
Domain	Helicase-assoc_dom	DHX40 YTHDC2 DQX1	3.94e-04	18	152	3	IPR007502
Domain	-	MON2 IPO8 RIPOR3 XPO1 MTOR INTS4 WDFY3 GCN1	4.76e-04	222	152	8	1.25.10.10
Domain	Serum_albumin-like	GC ALB	6.47e-04	5	152	2	IPR020858
Domain	Pentatricopeptide_repeat	IFT140 DENND4A PRORP	8.30e-04	23	152	3	IPR002885
Domain	ZF_BED	ZBED6 ZBED1	9.66e-04	6	152	2	PS50808
Domain	RIH_assoc-dom	RYR1 RYR3	9.66e-04	6	152	2	IPR013662
Domain	zf-BED	ZBED6 ZBED1	9.66e-04	6	152	2	PF02892
Domain	Ins145_P3_rec	RYR1 RYR3	9.66e-04	6	152	2	PF08709
Domain	RIH_assoc	RYR1 RYR3	9.66e-04	6	152	2	PF08454
Domain	RIH_dom	RYR1 RYR3	9.66e-04	6	152	2	IPR000699
Domain	Ins145_P3_rcpt	RYR1 RYR3	9.66e-04	6	152	2	IPR014821
Domain	Ryanodine_recept-rel	RYR1 RYR3	9.66e-04	6	152	2	IPR015925
Domain	-	RYR1 RYR3	9.66e-04	6	152	2	1.25.10.30
Domain	RYDR_ITPR	RYR1 RYR3	9.66e-04	6	152	2	PF01365
Domain	ALB/AFP/VDB	GC ALB	9.66e-04	6	152	2	IPR000264
Domain	HEAT	XPO1 MTOR INTS4 GCN1	1.27e-03	58	152	4	IPR000357
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	KIF23 MYL6 ANK3 MCCC1 SPATA2 PKHD1L1 ADD1 CASK WDR3 FAT1 THADA GTPBP2 SUGP2 UBR5 ZBED6 NOM1 VPS13A MRPS9 ALB GCN1	3.27e-10	777	155	20	35844135
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MON2 RPL10L HIVEP1 DDX31 DHX40 DAXX ZDBF2 MCCC1 PPP4R3B TBC1D4 UBR5 CCNB2 MACF1 MTREX ZMYM6 SORL1	9.95e-09	588	155	16	38580884
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	ASXL1 HIVEP1 MYL6 CEP85L DHX40 PPIL4 YTHDC2 DPP3 CLPX SPATA2 CASK WDR3 USP14 UBR5 VPS35 ALB MTCL1 TMX3 GCN1 ZMYM6	2.52e-08	1005	155	20	19615732
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	KIF23 IL18 DHX40 PPIL4 XPO1 MCCC1 CLPX ECT2 WDR3 USP14 TBC1D4 SBF1 SUGP2 UBR5 SERPINB12 VPS35 A2ML1 MACF1 PRKCD WDFY3 MTREX GCN1 GOT2	3.76e-08	1353	155	23	29467282
Pubmed	Down-regulation of JAK1 by RNA interference inhibits growth of the lung cancer cell line A549 and interferes with the PI3K/mTOR pathway.	JAK1 PIK3CA MTOR	8.68e-08	3	155	3	21861134
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	DENND4A KIF23 HIVEP1 MYL6 IPO8 PPIL4 CARS1 YTHDC2 UFL1 XPO1 CLPX TFCP2 WDR3 THADA MTOR SERPINB12 VPS35 MRPS9 PRKCD MTREX GCN1 NNT GOT2	9.56e-08	1425	155	23	30948266
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	MON2 ATP6V1B2 IPO8 CEP85L FASTKD1 YTHDC2 SUGP2 INTS2 UBR5 MTOR MRPS9 NINL INTS4 MTREX GCN1 NNT	2.96e-07	754	155	16	33060197
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	ASXL1 DDX31 DAXX MYSM1 JAK1 FAT1 SBF1 ZBED6 SHOC1 MACF1 MTCL1	3.24e-07	332	155	11	37433992
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	ZDBF2 WDR3 SUGP2 INTS2 UBR5 NOM1 MRPS9 MACF1 MTREX GCN1	6.11e-07	282	155	10	23667531
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MON2 IFT140 MYL6 RBL1 YTHDC2 CLPX JAK1 FAT1 THADA GTPBP2 SUGP2 UBR5 ZNF827 CAPRIN2 MACF1 WDFY3 BRD1 TMX3 SORL1	6.27e-07	1116	155	19	31753913
Pubmed	IL-27 inhibits IFN-γ induced autophagy by concomitant induction of JAK/PI3 K/Akt/mTOR cascade and up-regulation of Mcl-1 in Mycobacterium tuberculosis H37Rv infected macrophages.	JAK1 PIK3CA MTOR	8.63e-07	5	155	3	25194337
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	IFT27 TANK MYL6 IPO8 CEP85L DHX40 MCCC1 SPATA2 CFI TFCP2 WDR3 HROB UBR5 CCNB2 CNKSR3 NINL	1.49e-06	853	155	16	28718761
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DENND4A KIF23 HIVEP1 CEP85L MCCC1 ECT2 FSIP2 PTK2B TBC1D4 SBF1 MTOR CNKSR3 MACF1 MTCL1 MTREX BRD1	1.68e-06	861	155	16	36931259
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	MON2 IPO8 DHX40 PPIL4 YTHDC2 XPO1 CASK MTMR7 SBF1 UBR5 MTOR VPS35 PRKAB1 PRORP TMX3 GCN1 SORL1	1.83e-06	974	155	17	28675297
Pubmed	Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy.	TANK RBL1 XPO1 CASK JAK1 FAT1 CCNB2 PRKAB1 MTCL1 MTREX GCN1	2.05e-06	401	155	11	25852190
Pubmed	Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins.	DENND4A KIF23 HECTD4 XPO1 PANK1 TBC1D4 MTOR GCN1	2.37e-06	190	155	8	15161933
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	TANK MYL6 RBL1 HMMR JAK1 TYRO3 PTK2B INTS2 CCNB2 PRKAB1 CIBAR2 PRKCD CCDC106 MERTK UBASH3B MAP2K5	3.41e-06	910	155	16	36736316
Pubmed	Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death.	RYR1 RYR3 ATP2A3	4.78e-06	8	155	3	19033399
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	DENND4A YTHDC2 ZDBF2 ADD1 TBC1D4 UBR5 MACF1 MTCL1	4.80e-06	209	155	8	36779422
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MON2 ATP6V1B2 DDX31 ANK3 XPO1 CLPX CASK PPP4R3B MTMR7 TBC1D4 PTPRB SBF1 ATXN2 CCNB2 VPS13A INTS4 GCN1	4.89e-06	1049	155	17	27880917
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	PPIL4 DAXX YTHDC2 HMMR MCCC1 TFCP2 ADD1 SBF1 SUGP2 ATXN2 NOM1 MACF1 GCN1 NNT	4.93e-06	724	155	14	36232890
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	DENND4A RBL1 DHX40 YTHDC2 HMMR CLPX ECT2 GTPBP2 SBF1 NOM1 MTREX ZBED1 SORL1	7.62e-06	650	155	13	38777146
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	KIF23 DDX31 YTHDC2 XPO1 WDR3 SBF1 SUGP2 UBR5 MTOR MACF1 MTREX GCN1 NNT	8.00e-06	653	155	13	22586326
Pubmed	SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis.	MON2 MYL6 IPO8 XPO1 JAK1 THADA INTS2 UBR5 MTOR NOM1 VPS13A TMX3 GCN1	8.54e-06	657	155	13	36180527
Pubmed	ZBED evolution: repeated utilization of DNA transposons as regulators of diverse host functions.	ZBED6 ZBED1 ZMYM6	1.02e-05	10	155	3	23533661
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ATP6V1B2 DDX31 IPO8 ANK3 UFL1 NSL1 HMMR CLPX TFCP2 ADD1 CASK WDR3 THADA SBF1 UBR5 VPS35 VPS13A MRPS9 MACF1 TMX3	1.10e-05	1487	155	20	33957083
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	IPO8 FASTKD1 UFL1 XPO1 TFCP2 JAK1 FAT1 THADA SBF1 MTCL1 MME PRORP TMX3	1.41e-05	689	155	13	36543142
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	ANK3 GC YTHDC2 HMMR XPO1 KMO RYR3 PTPRB KIAA0825 VPS35 ATP2A3	1.55e-05	497	155	11	36774506
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	KIF23 MYL6 PPIL4 UFL1 JAK1 SUGP2 NOM1 VPS35 MRPS9 MACF1 MTCL1 GCN1	1.75e-05	601	155	12	33658012
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	DENND4A KIF23 MYL6 UFL1 CLPX JAK1 PPP4R3B TBC1D4 UBR5 ATXN2 NOM1 VPS35 PRKAB1 MRPS9 MTREX ATP2A3 GCN1 GOT2	1.81e-05	1284	155	18	17353931
Pubmed	CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1.	XPO1 SPATA2 VPS35 ALB MTCL1 MTREX GCN1	1.86e-05	182	155	7	31067453
Pubmed	Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics.	MON2 IPO8 XPO1 THADA MTOR UBASH3B GCN1	1.92e-05	183	155	7	23956138
Pubmed	Differential effects of inhibitors of the PI3K/mTOR pathway on the expansion and functionality of regulatory T cells.	PIK3CA MTOR	1.97e-05	2	155	2	27189717
Pubmed	Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival.	ASXL1 GATA2	1.97e-05	2	155	2	22271902
Pubmed	Carbachol stimulates TYR phosphorylation and association of PKCdelta and PYK2 in pancreas.	PTK2B PRKCD	1.97e-05	2	155	2	11352632
Pubmed	Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.	MTOR PRKAB1	1.97e-05	2	155	2	18006825
Pubmed	Contractile impairment and structural alterations of skeletal muscles from knockout mice lacking type 1 and type 3 ryanodine receptors.	RYR1 RYR3	1.97e-05	2	155	2	9489997
Pubmed	Follicular lymphoma-associated mutations in vacuolar ATPase ATP6V1B2 activate autophagic flux and mTOR.	ATP6V1B2 MTOR	1.97e-05	2	155	2	30720463
Pubmed	Dual targeting of phosphoinositide 3-kinase and mammalian target of rapamycin using NVP-BEZ235 as a novel therapeutic approach in human ovarian carcinoma.	PIK3CA MTOR	1.97e-05	2	155	2	21372221
Pubmed	Rare genetic variants in Tunisian Jewish patients suffering from age-related macular degeneration.	CFI HMCN1	1.97e-05	2	155	2	25986072
Pubmed	Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation.	ASXL1 GATA2	1.97e-05	2	155	2	24077845
Pubmed	PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer.	PIK3CA MTOR	1.97e-05	2	155	2	20479250
Pubmed	[PI3K and mTOR pathway and molecular targeted agents].	PIK3CA MTOR	1.97e-05	2	155	2	26281684
Pubmed	Structural insights of a PI3K/mTOR dual inhibitor with the morpholino-triazine scaffold.	PIK3CA MTOR	1.97e-05	2	155	2	26956874
Pubmed	Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development.	RYR1 RYR3	1.97e-05	2	155	2	17118445
Pubmed	Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone.	XPO1 MTOR	1.97e-05	2	155	2	27693556
Pubmed	Ehrlichia Activation of Wnt-PI3K-mTOR Signaling Inhibits Autolysosome Generation and Autophagic Destruction by the Mononuclear Phagocyte.	PIK3CA MTOR	1.97e-05	2	155	2	28993455
Pubmed	Signals mediating skeletal muscle remodeling by resistance exercise: PI3-kinase independent activation of mTORC1.	PIK3CA MTOR	1.97e-05	2	155	2	21071597
Pubmed	Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancer.	PIK3CA MTOR	1.97e-05	2	155	2	25497009
Pubmed	Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis.	TYRO3 MERTK	1.97e-05	2	155	2	21496228
Pubmed	Superior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLC.	PIK3CA MTOR	1.97e-05	2	155	2	27507059
Pubmed	Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene.	RYR1 RYR3	1.97e-05	2	155	2	12565913
Pubmed	Functional and morphological features of skeletal muscle from mutant mice lacking both type 1 and type 3 ryanodine receptors.	RYR1 RYR3	1.97e-05	2	155	2	9192302
Pubmed	Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells.	PIK3CA MTOR	1.97e-05	2	155	2	20857497
Pubmed	AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells.	MTOR PRKAB1	1.97e-05	2	155	2	20196784
Pubmed	Isolation and partial cloning of ryanodine-sensitive Ca2+ release channel protein isoforms from human myometrial smooth muscle.	RYR1 RYR3	1.97e-05	2	155	2	7556644
Pubmed	Deubiquitylation and stabilization of Acf7 by ubiquitin carboxylterminal hydrolase 14 (USP14) is critical for NSCLC migration.	USP14 MACF1	1.97e-05	2	155	2	33737492
Pubmed	Regulation of bone homeostasis by MERTK and TYRO3.	TYRO3 MERTK	1.97e-05	2	155	2	36509738
Pubmed	Nlrp1b1 negatively modulates obesity-induced inflammation by promoting IL-18 production.	IL18 NLRP1	1.97e-05	2	155	2	31554824
Pubmed	Ubash3b promotes TPA-mediated suppression of leukemogenesis through accelerated downregulation of PKCδ protein.	PRKCD UBASH3B	1.97e-05	2	155	2	33556471
Pubmed	Increased Circulating and Urinary Levels of Soluble TAM Receptors in Diabetic Nephropathy.	TYRO3 MERTK	1.97e-05	2	155	2	28668213
Pubmed	The block of ryanodine receptors selectively inhibits fetal myoblast differentiation.	RYR1 RYR3	1.97e-05	2	155	2	12640042
Pubmed	PI3K-mTORC2 but not PI3K-mTORC1 regulates transcription of HIF2A/EPAS1 and vascularization in neuroblastoma.	MTOR EPAS1	1.97e-05	2	155	2	26432405
Pubmed	Helicobacter pylori promotes eukaryotic protein translation by activating phosphatidylinositol 3 kinase/mTOR.	PIK3CA MTOR	1.97e-05	2	155	2	25194338
Pubmed	The role and molecular mechanism of metabolic reprogramming of colorectal cancer by UBR5 through PYK2 regulation of OXPHOS expression study.	PTK2B UBR5	1.97e-05	2	155	2	37098808
Pubmed	Possible involvement of ryanodine receptor-mediated intracellular calcium release in the effect of corticotropin-releasing factor on adrenocorticotropin secretion.	RYR1 RYR3	1.97e-05	2	155	2	14592949
Pubmed	mTOR Activation Underlies Enhanced B Cell Proliferation and Autoimmunity in PrkcdG510S/G510S Mice.	MTOR PRKCD	1.97e-05	2	155	2	36961448
Pubmed	Reciprocal regulation of Daxx and PIK3CA promotes colorectal cancer cell growth.	DAXX PIK3CA	1.97e-05	2	155	2	35718818
Pubmed	Morphological abnormalities of adrenal gland and hypertrophy of liver in mutant mice lacking ryanodine receptors.	RYR1 RYR3	1.97e-05	2	155	2	9799464
Pubmed	Novel targeting of phosphatidylinositol 3-kinase and mammalian target of rapamycin in renal cell carcinoma.	PIK3CA MTOR	1.97e-05	2	155	2	23867512
Pubmed	Dual inhibition of PI3K and mTOR signaling pathways decreases human pancreatic neuroendocrine tumor metastatic progression.	PIK3CA MTOR	1.97e-05	2	155	2	24263107
Pubmed	Frameshift mutations of vacuolar protein sorting genes in gastric and colorectal cancers with microsatellite instability.	VPS35 VPS13A	1.97e-05	2	155	2	21733561
Pubmed	RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle.	RYR1 RYR3	1.97e-05	2	155	2	11500519
Pubmed	Glial tumor cell adhesion is mediated by binding of the FNIII domain of receptor protein tyrosine phosphatase beta (RPTPbeta) to tenascin C.	TNC PTPRB	1.97e-05	2	155	2	11313993
Pubmed	In pursuit of synergy: An investigation of the PI3K/mTOR/MEK co-targeted inhibition strategy in NSCLC.	PIK3CA MTOR	1.97e-05	2	155	2	27765909
Pubmed	Phosphodiesterase-5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide-mediated lipolysis.	PDE5A MME	1.97e-05	2	155	2	17906676
Pubmed	Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction.	RYR1 RYR3	1.97e-05	2	155	2	15894801
Pubmed	The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancer.	PIK3CA MTOR	1.97e-05	2	155	2	25491778
Pubmed	Effect of calmodulin on Ca2+-induced Ca2+ release of skeletal muscle from mutant mice expressing either ryanodine receptor type 1 or type 3.	RYR1 RYR3	1.97e-05	2	155	2	9817784
Pubmed	[Advances of LKB1-AMPK-mTOR Signaling Pathway in Tumor].	MTOR PRKAB1	1.97e-05	2	155	2	21859551
Pubmed	HIF2α Upregulates the Migration Factor ODZ1 under Hypoxia in Glioblastoma Stem Cells.	TENM1 EPAS1	1.97e-05	2	155	2	35054927
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	MON2 KIF23 IPO8 YTHDC2 UFL1 XPO1 MCCC1 CLPX WDR3 USP14 THADA UBR5 MTOR NOM1 VPS35 MRPS9 MTREX TMX3 GCN1	2.41e-05	1440	155	19	30833792
Pubmed	The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.	ATP6V1B2 DDX31 DAXX YTHDC2 TFCP2 WDR3 SUGP2 ATXN2 MTREX	2.90e-05	349	155	9	25665578
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	KIF23 DDX31 HECTD4 DAXX YTHDC2 WDR3 PPP4R3B SBF1 UBR5 MTREX	3.05e-05	440	155	10	34244565
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	DENND4A KIF23 HIVEP1 ANK3 YTHDC2 ECT2 FAT1 MACF1 MTCL1	3.76e-05	361	155	9	26167880
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	KIF23 DDX31 IPO8 YTHDC2 HMMR XPO1 ECT2 WDR3 SUGP2 NOM1 MACF1 MTREX GCN1	3.84e-05	759	155	13	35915203
Pubmed	Mapping a dynamic innate immunity protein interaction network regulating type I interferon production.	HIVEP1 TANK RBL1 YTHDC2 HMMR JAK1 GTPBP2 VPS35	4.27e-05	283	155	8	21903422
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	YTHDC2 XPO1 RYR1 TBC1D4 CAPRIN2 VPS13A SORL1	4.35e-05	208	155	7	33230847
Pubmed	Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation.	KIF23 TNC ADD1 CASK JAK1 FAT1 ALCAM MME	4.48e-05	285	155	8	21423176
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	MON2 XPO1 MCCC1 ADD1 CASK WDR3 VPS35 INTS4 MTREX TMX3 NNT	4.59e-05	560	155	11	35241646
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	KIF23 NSL1 HMMR WDR3 SUGP2 UBR5 MTCL1	4.63e-05	210	155	7	16565220
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR1 RYR3	5.90e-05	3	155	2	18403125
Pubmed	[Study of gambogenic acid-induced apoptosis of melanoma B16 cells through PI3K/Akt/mTOR signaling pathways].	PIK3CA MTOR	5.90e-05	3	155	2	25095381
Pubmed	Characterization and mapping of the 12 kDa FK506-binding protein (FKBP12)-binding site on different isoforms of the ryanodine receptor and of the inositol 1,4,5-trisphosphate receptor.	RYR1 RYR3	5.90e-05	3	155	2	11171121
Pubmed	High incidence of distal vaginal atresia in mice lacking Tyro3 RTK subfamily.	TYRO3 MERTK	5.90e-05	3	155	2	18393392
Pubmed	Inhibition of the PI3K/Akt/mTOR signaling pathway in diffuse large B-cell lymphoma: current knowledge and clinical significance.	PIK3CA MTOR	5.90e-05	3	155	2	25215588
Pubmed	The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation.	MTOR PRKAB1	5.90e-05	3	155	2	20668229
Pubmed	The role of Tyro 3 subfamily receptors in the regulation of hemostasis and megakaryocytopoiesis.	TYRO3 MERTK	5.90e-05	3	155	2	17488688
Pubmed	Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis.	TYRO3 MERTK	5.90e-05	3	155	2	30335822
Pubmed	Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer.	PIK3CA MTOR	5.90e-05	3	155	2	27626684
Interaction	OPALIN interactions	MON2 IPO8 CRACR2A FASTKD1 JAK1 THADA SBF1 INTS2 MTOR PRKCD WDFY3 GCN1	5.98e-08	209	151	12	int:OPALIN
Interaction	GPR45 interactions	MON2 IPO8 CRACR2A FASTKD1 UFL1 XPO1 JAK1 THADA INTS2 MTOR NOM1 WDFY3 ATP2A3 GCN1	6.16e-08	300	151	14	int:GPR45
Interaction	FPR1 interactions	IPO8 FASTKD1 UFL1 XPO1 THADA INTS2 MTOR WDFY3 GCN1	1.67e-06	147	151	9	int:FPR1
Interaction	CD40 interactions	MON2 TANK IPO8 THADA INTS2 PIK3CA MTOR ATP2A3 GCN1	2.33e-06	153	151	9	int:CD40
Interaction	P2RY10 interactions	MON2 FASTKD1 XPO1 JAK1 THADA INTS2 WDFY3	1.51e-05	106	151	7	int:P2RY10
Interaction	HSPA7 interactions	KIF23 ECT2 TFCP2 KMO UBASH3B MAP2K5	1.80e-05	73	151	6	int:HSPA7
Interaction	CNTNAP4 interactions	KIF23 ECT2 CASK MACF1	1.99e-05	22	151	4	int:CNTNAP4
Interaction	COMTD1 interactions	IPO8 UFL1 XPO1 PPP4R3B THADA INTS2 MTOR INTS4 GCN1	2.04e-05	200	151	9	int:COMTD1
Interaction	CD274 interactions	IPO8 CRACR2A XPO1 JAK1 WDR3 THADA INTS2 MTOR SERPINB12 ATP2A3 GCN1 GOT2	2.27e-05	369	151	12	int:CD274
Interaction	BTNL9 interactions	MON2 IPO8 CRACR2A THADA SBF1 INTS2 INTS4 ATP2A3	2.35e-05	156	151	8	int:BTNL9
Interaction	TRIM66 interactions	MON2 IFT140 YTHDC2 JAK1 FAT1 THADA GTPBP2 WDFY3 TMX3	2.48e-05	205	151	9	int:TRIM66
Interaction	HNRNPU interactions	RPL10L ASXL1 KIF23 GALE DDX31 KRBA2 YTHDC2 UFL1 ECT2 TFCP2 WDR3 PPP4R3B USP14 GTPBP2 UBR5 ATXN2 MRPS9 PADI6 MTREX UBASH3B GCN1	3.08e-05	1035	151	21	int:HNRNPU
Interaction	APLNR interactions	IPO8 FASTKD1 UFL1 XPO1 CPT2 JAK1 THADA INTS2 MTOR	3.12e-05	211	151	9	int:APLNR
Interaction	HAVCR2 interactions	CLDND1 JAK1 SBF1 PIK3CA CNKSR3 ZMYM6	3.76e-05	83	151	6	int:HAVCR2
Interaction	GPR182 interactions	MON2 IPO8 FASTKD1 UFL1 XPO1 JAK1 THADA MTOR NOM1 WDFY3 PRORP ATP2A3 GCN1	3.97e-05	455	151	13	int:GPR182
Interaction	FAM234A interactions	FASTKD1 XPO1 THADA INTS2 MTOR MME WDFY3	4.62e-05	126	151	7	int:FAM234A
Interaction	MFSD4A interactions	MON2 IPO8 FASTKD1 XPO1 JAK1 THADA MTOR NOM1 GCN1	5.14e-05	225	151	9	int:MFSD4A
Interaction	TACSTD2 interactions	MON2 FASTKD1 THADA INTS2 MTOR INTS4 WDFY3	5.37e-05	129	151	7	int:TACSTD2
Interaction	B3GALT6 interactions	CYP2C18 MCPH1 UFL1 ATP2A3	5.39e-05	28	151	4	int:B3GALT6
Interaction	GPR17 interactions	IPO8 FASTKD1 UFL1 XPO1 PPP4R3B THADA INTS2 MTOR WDFY3 ATP2A3	5.60e-05	283	151	10	int:GPR17
Interaction	LDB3 interactions	KLHL41 TFCP2 PRKCD ALB	6.22e-05	29	151	4	int:LDB3
Interaction	P2RY8 interactions	MON2 IPO8 FASTKD1 THADA INTS2 MTOR ATP2A3 GCN1	6.25e-05	179	151	8	int:P2RY8
Interaction	FAAH interactions	CYP19A1 MME ATP2A3	6.51e-05	11	151	3	int:FAAH
Interaction	PRKDC interactions	ASXL1 KIF23 IL18 UFL1 ECT2 TFCP2 TYRO3 USP14 THADA UBR5 MTOR NINL PRKCD MERTK GCN1 EPAS1	6.84e-05	695	151	16	int:PRKDC
Interaction	ADD2 interactions	KIF23 ADD1 VPS13A INTS4 PRKCD MME	7.14e-05	93	151	6	int:ADD2
Interaction	SCN2B interactions	FASTKD1 THADA INTS2 MTOR PRORP GCN1	8.04e-05	95	151	6	int:SCN2B
Interaction	SPTAN1 interactions	MON2 KIF23 ANK3 GATA2 UFL1 ECT2 TFCP2 ADD1 JAK1 USP14 UBR5 ALB UBASH3B	9.50e-05	496	151	13	int:SPTAN1
Interaction	YWHAZ interactions	ASXL1 DENND4A KIF23 HIVEP1 CEP85L HECTD4 UFL1 NSL1 XPO1 SPATA2 ECT2 FSIP2 TBC1D4 SBF1 MTOR SERPINB12 CNKSR3 MACF1 PRKCD WDFY3 MTREX BRD1 MAP2K5	1.28e-04	1319	151	23	int:YWHAZ
Interaction	EFNB1 interactions	MON2 IPO8 XPO1 JAK1 PPP4R3B THADA SBF1 INTS4 PRORP	1.34e-04	255	151	9	int:EFNB1
Interaction	NPY2R interactions	MON2 FASTKD1 XPO1 MTOR GCN1	1.37e-04	66	151	5	int:NPY2R
Interaction	MEX3A interactions	ASXL1 DDX31 DAXX MYSM1 JAK1 FAT1 SBF1 ZBED6 SHOC1 MACF1 MTCL1	1.55e-04	384	151	11	int:MEX3A
Interaction	MLNR interactions	IPO8 FASTKD1 UFL1 THADA INTS2	1.58e-04	68	151	5	int:MLNR
Interaction	PTGES3L interactions	PTGES3L SBF1	1.66e-04	3	151	2	int:PTGES3L
Interaction	OR3A2 interactions	UFL1 ALB	1.66e-04	3	151	2	int:OR3A2
Interaction	CA14 interactions	MON2 GALE THADA MTOR ATP2A3	1.93e-04	71	151	5	int:CA14
Interaction	EIF5B interactions	KIF23 UFL1 HMMR XPO1 ECT2 TFCP2 USP14 UBR5	2.02e-04	212	151	8	int:EIF5B
Interaction	PRSS1 interactions	ASXL1 GATA2 ALB EPAS1 SPINK5	2.20e-04	73	151	5	int:PRSS1
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR3	9.05e-05	3	100	2	287
GeneFamily	Zinc fingers BED-type\|Pseudoautosomal region 1	ZBED6 ZBED1	4.48e-04	6	100	2	64
GeneFamily	EF-hand domain containing	MYL6 CRACR2A EFCAB13 RYR3 NINL MACF1	1.36e-03	219	100	6	863
GeneFamily	Kelch like\|BTB domain containing	KLHL1 KLHL41 KLHL31	1.61e-03	42	100	3	617
GeneFamily	Fibronectin type III domain containing	TNC TYRO3 PTPRB MERTK SORL1	1.95e-03	160	100	5	555
GeneFamily	Integrator complex	INTS2 INTS4	3.03e-03	15	100	2	1366
GeneFamily	Myotubularins\|Phosphoinositide phosphatases	MTMR7 SBF1	3.03e-03	15	100	2	903
Coexpression	GSE3982_CTRL_VS_LPS_48H_DC_UP	DDX31 CYP2C18 ME3 TGFBR3 MTCL1 WDFY3 MERTK NNT SORL1	3.15e-06	200	155	9	M5375
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	MON2 TANK FASTKD1 CARS1 NSL1 DPP3 XPO1 TFCP2 KMO ADD1 RYR3 MMRN1 CUTC WDR3 TBC1D4 UBR5 PIK3CA C7orf25 MACF1 PRKCD ALCAM	1.03e-05	1215	155	21	M41122
Coexpression	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8	GATA2 TGFBR3 PTK2B USP14 CAPRIN2	1.16e-05	50	155	5	M16033
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	ASXL1 KIF23 XPO1 FAT1 UBR5 CCNB2 VPS13A PRKCD MTCL1 WDFY3	1.26e-05	300	155	10	M8702
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	ASXL1 KIF23 HIVEP1 TANK HMMR XPO1 CASK TGFBR3 FAT1 UBR5 ATXN2 VPS13A MACF1 ALCAM MTCL1 WDFY3 MTREX	1.34e-05	856	155	17	M4500
Coexpression	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8	GATA2 TGFBR3 PTK2B USP14 CAPRIN2	1.41e-05	52	155	5	MM874
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000	HMMR ECT2 WDR3 MTMR7 THADA UBR5 MTOR CCNB2 PDE5A PRORP MTREX	2.73e-05	333	151	11	gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	KIF23 TNC CLDND1 ZDBF2 HMMR ECT2 PANK1 GFRA2 TGFBR3 PTK2B FAT1 SCUBE1 HMCN1 PDE5A ALCAM MME TMX3	3.42e-05	768	151	17	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TNC RYR3 TGFBR3 FAT1 SCUBE1 SEMA6D MTCL1 UBASH3B	2.88e-07	185	155	8	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TNC RYR3 TGFBR3 FAT1 SCUBE1 SEMA6D MTCL1 UBASH3B	3.26e-07	188	155	8	4d1e5f85342ae550086609d7680e32730b78b5d2
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF23 GATA2 NSL1 HMMR ECT2 PTPRB CCNB2 EPAS1	4.47e-07	196	155	8	20383d576708b7e4bfce3e9fe40548cce496e3cb
ToppCell	LPS_anti-TNF-Epithelial_airway-airway_epithelial-Airway-Club\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SFTPB GC A2ML1 CIBAR2 ALB MME SDR16C5 SPINK5	4.83e-07	198	155	8	6712216c5a7fd86b68fd45b0ff7794975f19774e
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DENND4A HECTD4 RIPOR3 HMMR PKHD1L1 MMRN1 CCNB2 GPCPD1	5.02e-07	199	155	8	f894c88ecc7fd0edca28587801fa59352d10f750
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DENND4A HECTD4 RIPOR3 HMMR PKHD1L1 MMRN1 CCNB2 GPCPD1	5.02e-07	199	155	8	2b754670fe77c2301afcdcfc73a1e52cc0cd1de3
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DENND4A HECTD4 RIPOR3 HMMR PKHD1L1 MMRN1 CCNB2 GPCPD1	5.21e-07	200	155	8	f100edfd2b3b742458cbbf34de9c403c4d272d3c
ToppCell	Control-Epithelial_airway-Club_cells-Airway\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IL18 SFTPB A2ML1 ALB MME SDR16C5 SPINK5	2.09e-06	168	155	7	ce87981f4da2779de952c2e5d2bbcdabb265e705
ToppCell	Control-Epithelial_airway-Club_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IL18 SFTPB A2ML1 ALB MME SDR16C5 SPINK5	2.09e-06	168	155	7	e85bc5398eb36b2b0773a8a7082e3ba740452165
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF23 IL18 HMMR ECT2 MTMR7 CCNB2 MERTK	2.35e-06	171	155	7	845f312f8cbe29d820da25f0e6d75deb382bbfd8
ToppCell	3'_v3-blood-Mast\|blood / Manually curated celltypes from each tissue	GATA2 KMO ATP10D RYR3 MME SDR16C5 EPAS1	2.44e-06	172	155	7	e7a46bbeff749ca59b9f1357409ce1ad59dd22dd
ToppCell	PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF23 SFTPB HMMR ECT2 CCNB2 ALCAM SPINK5	2.95e-06	177	155	7	a68c3688f12aee22f3cb4049c4bccacbacb0fae6
ToppCell	E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HECTD4 GATA2 RIPOR3 SUGP2 VPS13A UBASH3B ATP2A3	3.30e-06	180	155	7	ca2a35bfb67347e47f511589a3d0f763e6664634
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PANK1 CASK HROB THADA TBC1D4 KIAA0825 MTOR	3.30e-06	180	155	7	a682a5d55c612709c9ee9fa4289d6f8bef7fe1af
ToppCell	E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HECTD4 GATA2 RIPOR3 SUGP2 VPS13A UBASH3B ATP2A3	3.30e-06	180	155	7	4e9e8cde2919610c4ac0025b1c9819808048bc1d
ToppCell	E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HECTD4 GATA2 RIPOR3 SUGP2 VPS13A UBASH3B ATP2A3	3.30e-06	180	155	7	466381bf93c3da6a2a241daadb68e9aad2964eae
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF23 GATA2 HMMR ECT2 PTPRB CCNB2 EPAS1	3.30e-06	180	155	7	b35a8c6169f4b548b912af005e92ae7c6596f376
ToppCell	droplet-Spleen-SPLEEN-1m-Lymphocytic-immature_NKT_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF23 NSL1 HMMR ECT2 TYRO3 CCNB2 CCDC106	3.95e-06	185	155	7	736bf89a7a1a840ab6920060f2d98598332065a0
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GATA2 HMMR MMRN1 TBC1D4 PTPRB CCNB2 EPAS1	4.09e-06	186	155	7	e9d12f2fcd346fc8d00f7178324ea5997628df8a
ToppCell	LV-10._Endothelium_II\|World / Chamber and Cluster_Paper	GATA2 PKHD1L1 ADD1 MMRN1 PTPRB HMCN1 EPAS1	4.24e-06	187	155	7	7876dcb4800c2e54874df3d933efb79307a64a97
ToppCell	facs-Spleen-nan-3m-Lymphocytic-CD79a_B_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GC KMO PTK2B MACF1 ALB ATP2A3 SORL1	4.24e-06	187	155	7	b51af2824e65734f333b1325117f4a2e88b17c23
ToppCell	facs-Spleen-nan-3m-Lymphocytic-B_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KMO PTK2B MACF1 PRKCD ALB ATP2A3 SORL1	4.24e-06	187	155	7	3ca3954f45f167e98a230f2847f0582d74fcd32e
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MYL6 RYR3 SEMA6D TENM1 MTCL1 UBASH3B ATP2A3	4.55e-06	189	155	7	b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f
ToppCell	Mesenchymal-airway_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	TNC RYR3 TGFBR3 FAT1 SCUBE1 SEMA6D MTCL1	4.71e-06	190	155	7	645e56b02edc3702c7db917b8ecd5eed0decaf71
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TNC JAK1 PTPRB HMCN1 MACF1 PDE5A EPAS1	4.71e-06	190	155	7	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	LPS_only-Endothelial-Endothelial-Vein\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KLHL1 ME3 MMRN1 TGFBR3 PTPRB HMCN1 CNKSR3	5.04e-06	192	155	7	52acaecd3703166f5ce3b328aff7c82bd142fee4
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	MON2 DENND4A ANK3 NLRP1 GPCPD1 MACF1 SORL1	5.04e-06	192	155	7	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	facs-Aorta-Heart-3m\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADD1 TBC1D4 VPS35 MACF1 ALB ALCAM MTREX	5.04e-06	192	155	7	1ccc47792edf9ee23501c8e2165d11271636b66a
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF23 TNC NSL1 HMMR ECT2 CCNB2 PDE5A	5.22e-06	193	155	7	a332dfdcc48c405020014e644aa4d14fda98cc86
ToppCell	facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GC BARX2 HMCN1 MACF1 ALB ALCAM ATP2A3	5.22e-06	193	155	7	eba3c70701b051bc1ed1f4db9270cb27a77ffc3e
ToppCell	RV-09._Endothelium_I\|World / Chamber and Cluster_Paper	GATA2 ADD1 MMRN1 PTPRB HMCN1 EPAS1 SPINK5	5.22e-06	193	155	7	e3fa47e2c7cd8a5b69186711c57751f2296de8ae
ToppCell	Children_(3_yrs)-Endothelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GATA2 PKHD1L1 MMRN1 TGFBR3 PTPRB CNKSR3 EPAS1	5.58e-06	195	155	7	094cf6591daa5ffad36e44122b6f524a3a34c2fd
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIF23 HMMR ECT2 PKHD1L1 MMRN1 PTPRB CCNB2	5.77e-06	196	155	7	eb8c9a4a5eb21d43ff7b25deae5896c236f669b9
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF23 GATA2 HMMR ECT2 PTPRB CCNB2 EPAS1	5.77e-06	196	155	7	0644bd14a944b9c9759a295dfdd5e67a4775f20a
ToppCell	5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GATA2 CFI RYR3 MMRN1 PTPRB HMCN1 EPAS1	5.97e-06	197	155	7	87eda06344498dc66cac292cf89746dc90b5cf67
ToppCell	COVID-19-kidney-Macrophages\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ATP6V1B2 IL18 PTK2B GPCPD1 ALCAM MERTK SORL1	5.97e-06	197	155	7	3912301018d0863144dcfac8d1fa8adc081748d7
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIF23 HMMR ECT2 PKHD1L1 MMRN1 PTPRB CCNB2	5.97e-06	197	155	7	76b61e60a757e58b465569538e632d6d9953e89a
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF23 GATA2 HMMR ECT2 PTPRB CCNB2 EPAS1	5.97e-06	197	155	7	1c89d6836eed30c50c765f7dde9cc8ee15c363d2
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW19-Stem_cells-Stem_cells\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	KIF23 HMMR CPT2 ECT2 ATP10D MMRN1 CCNB2	6.17e-06	198	155	7	50f236ab7ef6f00721f6cd714e3eee183077beeb
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW19-Stem_cells\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	KIF23 HMMR CPT2 ECT2 ATP10D MMRN1 CCNB2	6.17e-06	198	155	7	dc0c6189ff9dd76675f63acf1cbc7dda60e75f3f
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MON2 ANK3 TGFBR3 SUGP2 VPS13A TENM1 MACF1	6.37e-06	199	155	7	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	LPS_anti-TNF-Epithelial_airway-airway_epithelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	GC A2ML1 CIBAR2 ALB MME SDR16C5 SPINK5	6.37e-06	199	155	7	60919c2af31d39a2d36d7bc432e43dab2a4e05fb
ToppCell	LPS_anti-TNF-Epithelial_airway\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	GC A2ML1 CIBAR2 ALB MME SDR16C5 SPINK5	6.37e-06	199	155	7	6aca164bbbb961f34b1e6f1857f91ade5c059405
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	KIF23 TNC HMMR CPT2 ECT2 ATP10D CCNB2	6.59e-06	200	155	7	31dd81df9aa754a1e69b905bf9b8ce73ff8175aa
ToppCell	LPS_only-Endothelial-Endothelial-Vein\|LPS_only / Treatment groups by lineage, cell group, cell type	KLHL1 GATA2 MMRN1 TGFBR3 PTPRB SEMA6D EPAS1	6.59e-06	200	155	7	b036f5e22c95a3b14391785b6e91aa183b9bc9a8
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells-Neuroepithelial_cell\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	KIF23 TNC HMMR CPT2 ECT2 ATP10D CCNB2	6.59e-06	200	155	7	54174a485a82480726fa06efa6e050ddea77cb3c
ToppCell	LPS_only-Hematopoietic_Erythro-Megakary\|LPS_only / Treatment groups by lineage, cell group, cell type	DENND4A KIF23 HECTD4 HMMR PKHD1L1 MMRN1 CCNB2	6.59e-06	200	155	7	ce8281c9556a1f64f8ca8a029110077d4ef5b35e
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ANK3 TNC TGFBR3 FAT1 PDE5A ALCAM MTCL1	6.59e-06	200	155	7	c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c
ToppCell	moderate-Lymphoid-NKT-proliferating\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	KIF23 IL18 HMMR ECT2 CCNB2 ALCAM SDR16C5	6.59e-06	200	155	7	693adc310953b669c9b93e2e7a3346606f75c810
ToppCell	LPS_IL1RA-Epithelial_airway-airway_epithelial-Airway-Club\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	BTBD16 A2ML1 CIBAR2 ALB MME SDR16C5 SPINK5	6.59e-06	200	155	7	df90b67490cd649de3e3a713762ffbc34a698899
ToppCell	LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid\|LPS_only / Treatment groups by lineage, cell group, cell type	DENND4A KIF23 HECTD4 HMMR PKHD1L1 MMRN1 CCNB2	6.59e-06	200	155	7	83c4181c083b364f0d3a89ae7a0504781fa9fa9f
ToppCell	LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega\|LPS_only / Treatment groups by lineage, cell group, cell type	DENND4A KIF23 HECTD4 HMMR PKHD1L1 MMRN1 CCNB2	6.59e-06	200	155	7	f15baf287ec467664c23faa53fdea45257f7b9d0
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	NLRP1 NSL1 BARX2 CNKSR3 SPINK5	8.88e-06	80	155	5	0d02b242164d27f38f70ed77b106612fc7a3abca
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_2\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	NLRP1 NSL1 BARX2 CNKSR3 SPINK5	8.88e-06	80	155	5	313344cf7309bc17ca131b92a91b24489df577e2
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocyte.Tnr.Tmem2_(Tmem2)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	NLRP1 NSL1 BARX2 CNKSR3 SPINK5	8.88e-06	80	155	5	b95e4456adb7f7d42825351f010376c10bb35380
ToppCell	Fetal_29-31_weeks-Immune-mast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GATA2 RIPOR3 PKHD1L1 MMRN1 HROB ATP2A3	1.19e-05	145	155	6	dc89d817a9bef24a07e992efdab4136f12ceb399
ToppCell	droplet-Heart-nan-24m-Hematologic-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RUBCNL KMO RYR1 DQX1 UBASH3B GPR132	2.15e-05	161	155	6	7e60001637ef0f6fc67ef8a36ab80ebb25b0b0ab
ToppCell	facs-MAT-Fat-3m-Myeloid-macrophage\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DHX40 GFRA2 KMO RYR1 PRKCD ALCAM	2.39e-05	164	155	6	b81498c3934e0d52bf0329dc745e02966f9d8613
ToppCell	LPS-antiTNF-Epithelial_airway-Club_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 SFTPB ALB MME SDR16C5 SPINK5	2.56e-05	166	155	6	1df4bdf7c773cbfa6c93d7a901f9cd3f3fe07a3d
ToppCell	LPS-antiTNF-Epithelial_airway-Club_cells-Airway\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 SFTPB ALB MME SDR16C5 SPINK5	2.56e-05	166	155	6	9628522e7af8f8edca733588a364ab2454ac5ca5
ToppCell	normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	ANK3 NLRP1 ZDBF2 FSIP2 VPS13A PCBP4	2.83e-05	169	155	6	bea8aba1f3cc3d0e8d448c1c45f5354d26ebf850
ToppCell	droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BARX2 PTGES3L KMO RYR1 TBC1D4 ALCAM	2.92e-05	170	155	6	bf589c4297ccc90e5f51e3d0fcc229548af4fcef
ToppCell	droplet-Heart-4Chambers-21m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RBL1 RUBCNL RYR1 PTK2B HMCN1 WDFY3	3.02e-05	171	155	6	e852d0e8589eecf4a2e5fea039b52a67c5d58dbd
ToppCell	343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	GATA2 HMMR ECT2 RYR3 CCNB2 PADI6	3.02e-05	171	155	6	4ccd88cf812dd8bfdc55159c6f504e9c84e4f4fc
ToppCell	facs-Diaphragm-Limb_Muscle-18m-Endothelial-endothelial_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA2 GC PTPRB SEMA6D ALB EPAS1	3.22e-05	173	155	6	2a5ea28c65dd4ee03ba3d0bfe0c819b1d583f8da
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_1\|356C / Donor, Lineage, Cell class and subclass (all cells)	PANK1 HROB THADA TBC1D4 KIAA0825 MTOR	3.22e-05	173	155	6	e3cb7c8c09f937da6b8d673e9adfec5d94a15548
ToppCell	facs-Diaphragm-Limb_Muscle-18m-Endothelial\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA2 GC PTPRB SEMA6D ALB EPAS1	3.22e-05	173	155	6	6a7e4fa2d9d00f50decc89b535d8a68ec96de58a
ToppCell	PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	KLHL1 GATA2 PTPRB SEMA6D ATP2A3 EPAS1	3.33e-05	174	155	6	b4f3f5334803e5903bc496decf923f2e44f7fa3c
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_progenitors\|lymph-node_spleen / Manually curated celltypes from each tissue	KIF23 CYP19A1 GATA2 HMMR CCNB2 MME	3.33e-05	174	155	6	029394e107bf7ad58056d2216070aa2e964fff12
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ATP6V1B2 KIF23 IL18 NLRP1 HMMR ECT2	3.33e-05	174	155	6	65147b0f8c2ccadd5685430d31081520c157536a
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF23 HMMR ECT2 ME3 PTPRB CCNB2	3.44e-05	175	155	6	d43ae33a6256606ce848247cad32d74f21b38988
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIF23 TNC HMMR ECT2 RYR1 CCNB2	3.44e-05	175	155	6	9142ed8ca2f1c0c518deb21988221406f62fe38c
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF23 GALE RBL1 HMMR ECT2 CCNB2	3.44e-05	175	155	6	8958c5c30437d20a4abd70d7527990f7e2a68b93
ToppCell	3'_v3-blood-Mast-Mast_cells\|blood / Manually curated celltypes from each tissue	GATA2 ATP10D RYR3 SCUBE1 MTCL1 EPAS1	3.55e-05	176	155	6	b9da3deaf62622d47eb30b6be7548253eee95597
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF23 NSL1 HMMR ECT2 CCNB2 PDE5A	3.66e-05	177	155	6	2b63f0529ef73e0eede9b7ef1f08b0a0426a9c82
ToppCell	E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DENND4A GATA2 RIPOR3 MMRN1 VPS13A UBASH3B	3.66e-05	177	155	6	84591e28482ab62a5ef41e61043eb64912766356
ToppCell	E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DENND4A GATA2 RIPOR3 MMRN1 VPS13A UBASH3B	3.66e-05	177	155	6	4bc100062891d07cacd10ffba38966cc6302c92f
ToppCell	E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DENND4A GATA2 RIPOR3 MMRN1 VPS13A UBASH3B	3.66e-05	177	155	6	9f3a2adb9cd4f0a059afc87b6e377a9702154bb1
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF23 SFTPB HMMR ECT2 CCNB2 ALCAM	3.66e-05	177	155	6	3081ce5fc66a1bb833719d6c0e0a6fc7115eeb91
ToppCell	droplet-Lung-30m-Epithelial-alveolar_epithelial\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ANK3 SFTPB MTCL1 MME CNGA2 SPINK5	3.78e-05	178	155	6	76e71fff99cf64302e2e3c0d66dd8ba0ff13624e
ToppCell	droplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ANK3 SFTPB MTCL1 MME CNGA2 SPINK5	3.78e-05	178	155	6	82f78ea1ea3ff3e2347cd8bc2f06e2a10e96f220
ToppCell	droplet-Lung-30m-Epithelial\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ANK3 SFTPB MTCL1 MME CNGA2 SPINK5	3.78e-05	178	155	6	5442bc52b8e902da1383f44d97a9f95e471a8d4d
ToppCell	droplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ANK3 SFTPB MTCL1 MME CNGA2 SPINK5	3.78e-05	178	155	6	523b286ebe0359c7f1902f28cbd71f452626fc0d
ToppCell	facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KMO RYR1 TBC1D4 PRKCD ALCAM GPR132	3.90e-05	179	155	6	33ed9270d257895ff3b40df2c1af878119c9f492
ToppCell	10x5'-blood-Lymphocytic_NK-Cycling_NK\|blood / Manually curated celltypes from each tissue	KIF23 HMMR ECT2 KLHL31 HROB CCNB2	3.90e-05	179	155	6	c93711273055a999335ba8d0f6500e4549f46cec
ToppCell	facs-Spleen-nan-3m-Lymphocytic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GC JAK1 PTK2B MACF1 ALB ATP2A3	4.02e-05	180	155	6	87fb1fdbc49c808bb5f6fe9fb747057b45fa78d0
ToppCell	10x5'-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac\|lymph-node_spleen / Manually curated celltypes from each tissue	KIF23 IL18 HMMR GFRA2 CCNB2 WDFY3	4.02e-05	180	155	6	4eea8366cdb82c356325ce88f09ad8b302c17a07
ToppCell	droplet-Lung-LUNG-30m-Epithelial-type_II_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 SFTPB MTCL1 MME CNGA2 SPINK5	4.15e-05	181	155	6	cadb18fc73031eb9f779599e15cd7861337fee78
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RYR3 TGFBR3 FAT1 SCUBE1 PDE5A MTCL1	4.15e-05	181	155	6	25915e2500430a902db37d79a749ce2990b69810
ToppCell	P15-Endothelial-proliferative_endothelial_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KIF23 NSL1 HMMR ECT2 HROB CCNB2	4.15e-05	181	155	6	0c5bc1660b8fc1e905ab4230202862de5be46ebd
ToppCell	P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KIF23 NSL1 HMMR ECT2 HROB CCNB2	4.15e-05	181	155	6	f83565f09dd971c5cad2704a4a86bca0accd955e
ToppCell	droplet-Lung-LUNG-30m-Epithelial-Alveolar_Epithelial_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 SFTPB MTCL1 MME CNGA2 SPINK5	4.15e-05	181	155	6	85bec4d3f255f4c61c790325eeb50ad38f709ef2
ToppCell	356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|356C / Donor, Lineage, Cell class and subclass (all cells)	KIF23 GATA2 RIPOR3 HMMR RYR3 CCNB2	4.15e-05	181	155	6	be4f35c9eb5b3083acb2264128f095fac1f3da45
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P1\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	NLRP1 ADD1 BTBD16 CNKSR3 SPINK5	4.16e-05	110	155	5	bede775886b45cce4aa229baead0e800b5be25a8
ToppCell	droplet-Lung-nan-3m-Epithelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 SFTPB ZNF827 CAPRIN2 MME SPINK5	4.28e-05	182	155	6	cfba75c1ffc39ac76db9e8e27394731942882b30
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF23 IL18 HMMR ECT2 MTMR7 CCNB2	4.28e-05	182	155	6	21dcab170ffeef89faa9fee5008568cb6e15c694
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF23 RBL1 NSL1 HMMR ECT2 CCNB2	4.28e-05	182	155	6	bc6a120dedc813c58baac1428c39851a07b71ba7
ToppCell	droplet-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 SFTPB ZNF827 CAPRIN2 MME SPINK5	4.28e-05	182	155	6	d836bfdc298ecd3558a973e393a329eb8bd59d79
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GATA2 CFI MMRN1 PTPRB HMCN1 EPAS1	4.28e-05	182	155	6	d0e3663f7d39f22a3ebd7fde56ab3504773598f4
ToppCell	droplet-Lung-nan-3m-Epithelial-type_II_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 SFTPB ZNF827 CAPRIN2 MME SPINK5	4.28e-05	182	155	6	7e7c7a26460d3003cdf0c0ffb96208a566aa09a7
Disease	breast cancer (is_implicated_in)	IL18 MCPH1 CYP19A1 HMMR PTK2B UBR5 PIK3CA	1.39e-05	150	153	7	DOID:1612 (is_implicated_in)
Disease	Congenital anosmia	TENM1 CNGA2	2.67e-05	2	153	2	C0393778
Disease	hepatocellular carcinoma (is_implicated_in)	IL18 GC XPO1 RYR3 JAK1 PIK3CA ALB	4.64e-05	181	153	7	DOID:684 (is_implicated_in)
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR1 RYR3	7.99e-05	3	153	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR1 RYR3	7.99e-05	3	153	2	DOID:8545 (implicated_via_orthology)
Disease	breast angiosarcoma (is_implicated_in)	PTPRB PIK3CA	7.99e-05	3	153	2	DOID:4511 (is_implicated_in)
Disease	lung non-small cell carcinoma (is_implicated_in)	SFTPB XPO1 JAK1 FAT1 PTPRB EPAS1	8.97e-05	139	153	6	DOID:3908 (is_implicated_in)
Disease	obesity (biomarker_via_orthology)	IL18 SFTPB MTOR PRKCD NNT GOT2	1.22e-04	147	153	6	DOID:9970 (biomarker_via_orthology)
Disease	polycystic kidney disease (biomarker_via_orthology)	TNC MTOR EPAS1	1.25e-04	19	153	3	DOID:0080322 (biomarker_via_orthology)
Disease	protein-energy malnutrition (biomarker_via_orthology)	CYP19A1 ALB	1.59e-04	4	153	2	DOID:11801 (biomarker_via_orthology)
Disease	kynurenate measurement	KMO GOT2	1.59e-04	4	153	2	EFO_0800141
Disease	Flushing	HECTD4 ATXN2	1.59e-04	4	153	2	HP_0031284
Disease	Lung Injury	TNC ALB MME	1.70e-04	21	153	3	C0273115
Disease	Chronic Lung Injury	TNC ALB MME	1.70e-04	21	153	3	C2350344
Disease	Myelodysplastic syndrome	ASXL1 GATA2	2.64e-04	5	153	2	cv:C3463824
Disease	MYELODYSPLASTIC SYNDROME	ASXL1 GATA2	2.64e-04	5	153	2	614286
Disease	Hemimegalencephaly	PIK3CA MTOR	3.95e-04	6	153	2	C0431391
Disease	pneumonia (is_marker_for)	IL18 TNC ALB	4.07e-04	28	153	3	DOID:552 (is_marker_for)
Disease	Malignant neoplasm of breast	TANK CEP85L CYP19A1 EFCAB13 HMMR ECT2 CUTC PIK3CA MTOR TENM1 MACF1 MME ATP2A3 CNGA2 SORL1	4.87e-04	1074	153	15	C0006142
Disease	Ischemic stroke, von Willebrand factor measurement	DDX31 HECTD4 ATXN2	5.01e-04	30	153	3	EFO_0004629, HP_0002140
Disease	monocyte count	ASXL1 DENND4A HIVEP1 IPO8 RIPOR3 GC XPO1 GFRA2 RYR1 TGFBR3 PTK2B THADA ATXN2 PRKAB1 PDE5A UBASH3B SORL1	5.15e-04	1320	153	17	EFO_0005091
Disease	quinolinate measurement	KMO ATXN2	5.51e-04	7	153	2	EFO_0800175
Disease	Neurodevelopmental delay	CARS1 MYSM1	5.51e-04	7	153	2	C4022738
Disease	centronuclear myopathy (implicated_via_orthology)	KLHL31 MTMR7	5.51e-04	7	153	2	DOID:14717 (implicated_via_orthology)
Disease	leukemia (is_marker_for)	DAXX ALB	5.51e-04	7	153	2	DOID:1240 (is_marker_for)
Disease	asphyxia neonatorum	THADA CLDN24 SEMA6D	6.07e-04	32	153	3	EFO_1000824
Disease	lymphocyte percentage of leukocytes	HIVEP1 RBL1 CYP19A1 GATA2 NSL1 THADA SP140L UBR5 ATXN2 PRKAB1 UBASH3B	7.30e-04	665	153	11	EFO_0007993
Disease	alcoholic hepatitis (is_marker_for)	IL18 ALB	7.33e-04	8	153	2	DOID:12351 (is_marker_for)
Disease	Liver Cirrhosis, Experimental	IL18 GC ECT2 KMO ATP10D FAT1 MTMR7 SEMA6D CCNB2 PRKCD ALB MME	7.41e-04	774	153	12	C0023893
Disease	right ventricular systolic volume measurement	TGFBR3 ATXN2 PDE5A	7.92e-04	35	153	3	EFO_0021815
Disease	pulmonary hypertension (biomarker_via_orthology)	TNC RYR1 RYR3 EPAS1	8.09e-04	80	153	4	DOID:6432 (biomarker_via_orthology)
Disease	endometrial cancer (is_implicated_in)	MCPH1 CYP19A1 JAK1	8.61e-04	36	153	3	DOID:1380 (is_implicated_in)
Disease	mean reticulocyte volume	KIF23 RBL1 XPO1 ME3 THADA TBC1D4 ATXN2 PIK3CA MTOR VPS13A INTS4 EPAS1	9.74e-04	799	153	12	EFO_0010701
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	RYR1 PIK3CA MTOR MERTK EPAS1	1.07e-03	148	153	5	C0279702
Disease	respiratory syncytial virus infectious disease (is_implicated_in)	IL18 SFTPB	1.17e-03	10	153	2	DOID:1273 (is_implicated_in)
Disease	unipolar depression, age at onset	FAT1 A2ML1 ALCAM	1.17e-03	40	153	3	EFO_0003761, EFO_0004847
Disease	peak expiratory flow	ANK3 ME3 TGFBR3 THADA CNKSR3 MTCL1 BRD1 NNT SORL1	1.21e-03	498	153	9	EFO_0009718
Disease	guanosine diphosphate measurement	TBC1D4 NINL	1.42e-03	11	153	2	EFO_0010494
Disease	gastric adenocarcinoma (is_implicated_in)	XPO1 UBR5	1.42e-03	11	153	2	DOID:3717 (is_implicated_in)
Disease	chemotherapy-induced alopecia, response to antimicrotubule agent	ME3 SERPINB12	1.42e-03	11	153	2	EFO_0005260, EFO_0005400
Disease	response to virus	CRACR2A MCPH1	1.42e-03	11	153	2	GO_0009615
Disease	Prostatic Neoplasms	IL18 CYP2C18 CYP19A1 XPO1 JAK1 PIK3CA INTS4 MME ZBED1 SPINK5	1.46e-03	616	153	10	C0033578
Disease	Malignant neoplasm of prostate	IL18 CYP2C18 CYP19A1 XPO1 JAK1 PIK3CA INTS4 MME ZBED1 SPINK5	1.46e-03	616	153	10	C0376358
Disease	psoriasis (is_marker_for)	IL18 CFI EPAS1	1.55e-03	44	153	3	DOID:8893 (is_marker_for)
Disease	autoimmune thrombocytopenic purpura (is_marker_for)	IL18 ALB	2.01e-03	13	153	2	DOID:8924 (is_marker_for)
Disease	Fetal Alcohol Spectrum Disorders	ANK3 PIK3CA	2.01e-03	13	153	2	C2985290
Disease	cognitive inhibition measurement	GFRA2 SEMA6D A2ML1	2.24e-03	50	153	3	EFO_0007969
Disease	Malformations of Cortical Development	PIK3CA MTOR	2.33e-03	14	153	2	C1955869
Disease	Cortical Dysplasia	PIK3CA MTOR	2.33e-03	14	153	2	C0431380
Disease	metabolite measurement	ANK3 MCPH1 MCCC1 CPT2 ATP10D ALCAM PCBP4 GOT2 SORL1	2.68e-03	560	153	9	EFO_0004725
Disease	Ischemic stroke, tissue plasminogen activator measurement	HECTD4 ATXN2	2.68e-03	15	153	2	EFO_0004791, HP_0002140
Disease	glycerate measurement	RYR3 HMCN1	2.68e-03	15	153	2	EFO_0021029
Disease	pulmonary hypertension (implicated_via_orthology)	TNC MTOR PDE5A	2.79e-03	54	153	3	DOID:6432 (implicated_via_orthology)
Disease	response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy	TANK PTPRB MTCL1	2.79e-03	54	153	3	EFO_0000180, EFO_0003100, GO_0061479
Disease	Ischemic stroke, plasminogen activator inhibitor 1 measurement	HECTD4 ATXN2	3.06e-03	16	153	2	EFO_0004792, HP_0002140
Disease	Urticaria	IL18 ALB	3.06e-03	16	153	2	C0042109
Disease	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	UBR5 MTOR	3.06e-03	16	153	2	C0334634
Disease	ovarian cancer (is_implicated_in)	CYP19A1 JAK1 PIK3CA	3.10e-03	56	153	3	DOID:2394 (is_implicated_in)
Disease	pre-eclampsia (is_marker_for)	ADD1 ALB EPAS1	3.42e-03	58	153	3	DOID:10591 (is_marker_for)
Disease	Benign neoplasm of stomach	UBR5 PIK3CA	3.45e-03	17	153	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	UBR5 PIK3CA	3.45e-03	17	153	2	C0496905
Disease	Carcinoma in situ of stomach	UBR5 PIK3CA	3.45e-03	17	153	2	C0154060
Disease	Fetal Alcohol Syndrome	ANK3 PIK3CA	3.45e-03	17	153	2	C0015923
Disease	factor XI measurement, Ischemic stroke	HECTD4 ATXN2	3.45e-03	17	153	2	EFO_0004694, HP_0002140
Disease	colorectal cancer (is_implicated_in)	XPO1 JAK1 FAT1 PIK3CA	3.69e-03	121	153	4	DOID:9256 (is_implicated_in)
Disease	Age-related macular degeneration	CFI HMCN1	3.87e-03	18	153	2	cv:C0242383
Disease	serum metabolite measurement	KLHL1 CYP2C18 MCPH1 GC MCCC1 CPT2 KMO ATP10D PRKCD ALCAM GOT2 SPINK5	3.89e-03	945	153	12	EFO_0005653
Disease	asthma (is_marker_for)	IL18 SFTPB TNC GC	4.26e-03	126	153	4	DOID:2841 (is_marker_for)
Disease	Phenyllactate (PLA) measurement	IPO8 GOT2	4.31e-03	19	153	2	EFO_0021662
Disease	diet measurement, HOMA-B	KLHL1 CNKSR3	4.31e-03	19	153	2	EFO_0004469, EFO_0008111
Disease	Juvenile Myelomonocytic Leukemia	ASXL1 GATA2	4.31e-03	19	153	2	C0349639
Disease	factor VIII measurement, Ischemic stroke	HECTD4 ATXN2	4.31e-03	19	153	2	EFO_0004630, HP_0002140
Disease	Sarcomatoid Renal Cell Carcinoma	RYR1 PIK3CA MTOR EPAS1	4.51e-03	128	153	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	RYR1 PIK3CA MTOR EPAS1	4.51e-03	128	153	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	RYR1 PIK3CA MTOR EPAS1	4.51e-03	128	153	4	C1266044
Disease	Papillary Renal Cell Carcinoma	RYR1 PIK3CA MTOR EPAS1	4.51e-03	128	153	4	C1306837
Disease	hypertension (implicated_via_orthology)	ADD1 MTOR PRKCD MME	4.51e-03	128	153	4	DOID:10763 (implicated_via_orthology)
Disease	Renal Cell Carcinoma	RYR1 PIK3CA MTOR EPAS1	4.51e-03	128	153	4	C0007134
Disease	neutrophil percentage of leukocytes	DENND4A HIVEP1 CYP19A1 GATA2 NSL1 THADA ATXN2 MERTK UBASH3B	4.68e-03	610	153	9	EFO_0007990
Disease	bone mineral content measurement	NLRP1 PTK2B SEMA6D ALCAM	4.76e-03	130	153	4	EFO_0007621
Disease	urinary microalbumin measurement	MON2 YTHDC2	4.77e-03	20	153	2	EFO_0010967
Disease	myocardial infarction (implicated_via_orthology)	RYR1 MTOR PDE5A	4.93e-03	66	153	3	DOID:5844 (implicated_via_orthology)
Disease	monocyte percentage of leukocytes	DENND4A IPO8 GATA2 GFRA2 ADD1 JAK1 THADA ATXN2 WDFY3 UBASH3B	4.94e-03	731	153	10	EFO_0007989
Disease	Microcephaly	CARS1 CASK GOT2	5.14e-03	67	153	3	C0025958
Disease	common carotid intimal medial thickness	CYP2C18 MCPH1 RYR3	5.14e-03	67	153	3	EFO_0004860
Disease	neutrophil count, eosinophil count	HECTD4 GC XPO1 THADA ATXN2	5.16e-03	213	153	5	EFO_0004833, EFO_0004842

Protein segments in the cluster

Peptide	Gene	Start	Entry
IEKLFAMDTEAKDQC	EPAS1	501	Q99814
EFEEDFDLIIDNCMK	BRD1	626	O95696
KDLQKFFCDFVTIEM	CIBAR2	176	Q6ZTR7
TQKADSPMDDFFQCV	CFI	216	P05156
IQEEVGMQCKDFDSF	CLDN24	56	A6NM45
VMCTAFHDNEETFLK	ALB	146	P02768
ALFSMDKCELNVTED	CLPX	531	O76031
LSQMCKALSIDFEEA	BTBD16	36	Q32M84
EEICESSSKMITFID	GTPBP2	246	Q9BX10
VADKIQFSVEMCFDN	A2ML1	546	A8K2U0
MLRKAQEFFQTCDAE	CRACR2A	51	Q9BSW2
LFEEFLELCKMQTAD	DAXX	66	Q9UER7
MELDDCSKFVQYETD	ATP2A3	576	Q93084
CFTEEDAKFMVDQLD	ETNPPL	416	Q8TBG4
LEEMDSKEQFSSFSC	ASXL1	1226	Q8IXJ9
DVDFYNEKMDSIVQC	ATP10D	406	Q9P241
FLQCVEKALEDMFDA	CPT2	636	P23786
KTQMFIRFIEECSFV	DENND4A	621	Q7Z401
SLAFFDDCVDKVDMD	DENND4A	641	Q7Z401
NEECVRKDFESSMNV	RUBCNL	376	Q9H714
DCPDELMEKSFDVNF	SDR16C5	136	Q8N3Y7
METSAKTACNVEEAF	RAB2B	146	Q8WUD1
VNFFEMSKETIIKCE	ECT2	551	Q9H8V3
KCLDFLVDMFNDEIE	INTS4	411	Q96HW7
DFDNILMTVTCFEKS	JAK1	471	P23458
DDMKEVAFSVRNAIC	MTCL1	1601	Q9Y4B5
EEDCEKAFFKMDNVL	PPIL4	291	Q8WUA2
QEASDNCFMDSDIKV	NSL1	96	Q96IY1
NCFMDSDIKVLEDQF	NSL1	101	Q96IY1
KFCDEKVSVDESVMS	FAT1	3746	Q14517
VSMIAFKLDEDLCAA	PCBP4	76	P57723
VDEFMCFIPTDDKNE	PADI6	481	Q6TGC4
FEFMDGADLCFEIVK	CASK	91	O14936
SIECRKMDTQEVEFS	PTPRB	1386	P23467
EFAESDQFMKLTFEQ	KLHL31	201	Q9H511
FIVDCNMETSTEEKE	MCPH1	586	Q8NEM0
DTVTEEMAKFLENFC	KIAA0825	281	Q8IV33
IEEFLSEAACMKDFS	MERTK	631	Q12866
CFSFNPMLDKEEREQ	MTMR7	111	Q9Y216
FLEDVDCKQSMRSED	PRKCD	121	Q05655
SMCEVFFQAEEEEKK	SPINK5	401	Q9NQ38
SMCEAFFQQEAKEKE	SPINK5	601	Q9NQ38
ECEDMLSKCRNDFKF	MMRN1	591	Q13201
REEIMESILFKCSDF	ATXN2	321	Q99700
KCSDFVVVQFKDMDS	ATXN2	331	Q99700
EKKCVEMFSQDLSVD	FSIP2	771	Q5CZC0
MCDFTEDQTAEFKEA	MYL6	1	P60660
FFVENRISICTEFMD	MAP2K5	231	Q13163
FMQVQKCTIFIVDED	PDE5A	361	O76074
ETDMELLVCTFCIKF	NLRP1	746	Q9C000
FAFEAMQKVDVVCLA	INTS2	21	Q9H0H0
QNMDATTEPCTDFFK	MME	71	P08473
RFVQICKEEDFMQLS	KLHL41	161	O60662
CTMEDAKLAQDFLDS	DPP3	176	Q9NY33
MACSLQKLFAVEEEF	HROB	1	Q8N3J3
TSEKFLVMASEDALC	GCN1	526	Q92616
SSFQSLKEFMDACDI	LCN10	151	Q6JVE6
EEFSKMCFETLLQFS	MON2	1576	Q7Z3U7
KATLFEVMFSDECIM	PPP4R3B	206	Q5MIZ7
KFEEDQKMVVFFSSC	DDX31	506	Q9H8H2
QKMVVFFSSCELVEF	DDX31	511	Q9H8H2
ELLCSMKEVSFDGND	HECTD4	1001	Q9Y4D8
EMFTQEELCKFIKFA	HECTD4	3901	Q9Y4D8
KALLASCEFDCVDEM	DQX1	476	Q8TE96
CEFDMVKDPEVQDFR	PIK3CA	126	P42336
AEMSCNKVEESERLF	MACF1	2806	Q9UPN3
KEDTSEFECVARNLM	HMCN1	4501	Q96RW7
SCTFQLLKMAFDEEV	SBF1	986	O95248
CSFQEEMVKEKNLFE	HMMR	361	O75330
IQEEVGMQCKDFDSF	CLDN22	56	Q8N7P3
KFFIEEMIRDLCQAD	GALE	161	Q14376
AECFEELSKCMQEKS	GATA2	411	P23769
GLECFETSVKEMENF	IFT27	146	Q9BW83
FSSFDADICTMVRQK	GPCPD1	501	Q9NPB8
FEDCLVFDELMDKFS	KMO	321	O15229
CQLDKFISSARMEAE	CCDC106	91	Q9BWC9
EDVSMKEENLCQAFS	CCNB2	96	O95067
ISTEEKLEECMDFAT	CYP19A1	266	P11511
MEEECEKFLRDFTEN	GFRA2	331	O00451
QLEAFMKDKELFACE	C7orf25	291	Q9BPX7
MIDEILSKETCDYFE	BARX2	26	Q9UMQ3
CTDEEQMFGFIERNK	FASTKD1	46	Q53R41
FCMTDDKVDKTLEQQ	ANK3	1331	Q12955
VIDQLFKEMSCCLFD	CEP85L	711	Q5SZL2
CNFMQESVLDFDKPS	CAPRIN2	631	Q6IMN6
SDFVSEDNMVNIKDC	EFCAB13	716	Q8IY85
FLSENMEFAELCKQE	MCCC1	131	Q96RQ3
DEFMQAVTDKFGINC	ME3	261	Q16798
FLMEVCVDSVESAVN	CUTC	26	Q9NTM9
DMNSARDFIDCFLIK	CYP2C18	256	P33260
LREEECVMKFFNTLA	PTK2B	241	Q14289
VEDNCINFVAMKFID	IL18	6	Q14116
EKSCELLFQMAESVD	DHX40	286	Q8IX18
EFEIETKMEEASDTC	SCUBE1	551	Q8IWY4
EAEKMELFVSFCEDT	RYR1	4226	P21817
ELFVSFCEDTIFEMQ	RYR1	4231	P21817
SDEKRFVCMLVTEDN	ALCAM	106	Q13740
DSKICFYDVEMDTVT	IFT140	596	Q96RY7
FKDIDSTCQVEILDM	KRBA2	256	Q6ZNG9
ADMITVQEFCKAEEV	KIF23	196	Q02241
TGCETFEEALEMAAK	PANK1	451	Q8TE04
SEDVIFSVMCYKDED	IPO8	351	O15397
IDFGDCFEVAMTREK	MTOR	2356	P42345
PVFQTEDKETCFDML	GPR132	176	Q9UNW8
FIEAEMKLFAQQCKE	NNT	296	Q13423
FNADEFEDMVAKKCL	RPL10L	176	Q96L21
VNMETARFFKSDFEE	ATP6V1B2	236	P21281
FGFKMSEDLSLEVCV	SORL1	686	Q92673
LMECFTSTFEDVKIL	THADA	791	Q6YHU6
KFDVFYCMNITDIDD	CARS1	86	P49589
AIFQDTMRKFLEQEC	SFTPB	86	P07988
DFEMIDCDLEDATKT	RBL1	901	P28749
QETLEAFVKEDFCMD	SHOC1	141	Q5VXU9
AFVKEDFCMDKVNFC	SHOC1	146	Q5VXU9
SEAVCQEKFNMEFRD	TANK	261	Q92844
EVEKSTQEMEFCETS	TENM1	66	Q9UKZ4
CTIMTSEDFLDAFEK	NOM1	661	Q5C9Z4
EFVKEMDDCHSTLEQ	NINL	416	Q9Y2I6
NKMFEDSEDSCRNLV	SP140L	86	Q9H930
SRDEMEEVQKQASCF	PRORP	456	O15091
MDSLVTANTKFCFDL	SERPINB12	1	Q96P63
EVFDALMVDSQKCSD	PRKAB1	161	Q9Y478
FTMVCKDADEAKRVE	GOT2	291	P00505
AFCEELESMIQEQFK	ADD1	66	P35611
CVSFTLTEQFMEKFV	CLDND1	106	Q9NY35
SDLFCLSKDDLMEAV	CNGA2	546	Q16280
TVQKDCFVAEMEDKV	CNK3/IPCEF1	166	G9CGD6
TVQKDCFVAEMEDKV	CNKSR3	166	Q6P9H4
MVVCKGFVEDLDESF	TMX3	21	Q96JJ7
VFECTLNMINKDFEE	XPO1	826	O14980
MVSFELFLAKVECEQ	SPATA2	161	Q9UM82
QDISFVSFTCVTEME	VPS13A	2176	Q96RL7
VSFTCVTEMEKTDLD	VPS13A	2181	Q96RL7
TFAVCEKFVVMEINN	WDFY3	1596	Q8IZQ1
EKKMVEEVFSNAIDC	MTREX	416	P42285
LAMAKALCSFVTEDE	MRPS9	346	P82933
FEKMDKLCSEQREVF	RIPOR3	921	Q96MK2
EACFILDTMKAETND	TFCP2	481	Q12800
KMELFVNFCEDTIFE	RYR3	4081	Q15413
IIGTFERMKCFSEEN	VPS35	631	Q96QK1
FQTLFELETETCAKM	SUGP2	351	Q8IX01
KAEALEVFCDMTSDG	TNC	2006	P24821
FEDCCQEKTAMDVFV	GC	296	P02774
EEFFSNMDCTQEEKH	ZDBF2	331	Q9HCK1
AEFQGAVEEMVSTKC	PKHD1L1	656	Q86WI1
IMECESFENIVEFLK	TBC1D4	1131	O60343
CTACDFVTMEEAEIK	ZNF827	931	Q17R98
EFSDECTTAERVLMK	YTHDC2	1206	Q9H6S0
VIQDFFCEHKSIENM	ZBED6	591	P86452
VDFFEQKSLEMECQN	ZMYM6	801	O95789
QIAEMELSDFKDCLT	STRCP1	1476	A6NGW2
QFFMCEDSKVDALGE	UBASH3B	131	Q8TF42
KRECEAKSEVMFFAD	WDR3	906	Q9UNX4
CEFVKSNTEQMREAF	ZBED1	76	O96006
FMEFCVEDSTDVHVL	PTGES3L	61	E9PB15
FETTMKCTESEEEEV	USP14	251	P54578
SAVCAFSMDDIEKVF	SEMA6D	326	Q8NFY4
EKEFLCENVFSEMSQ	HIVEP1	1701	P15822
DIEEFLREAACMKEF	TYRO3	561	Q06418
EKFINDCTELFRELM	UFL1	366	O94874
CDNEKMIVAVEKDSF	TGFBR3	456	Q03167
SAMDLAFAIDLCKEE	UBR5	2596	O95071
FTSDVCEAKQEEIKM	KLHL1	241	Q9NR64
ESMDQEIKFFRCLFE	KRT71	256	Q3SY84
SKVTNCFMAEEFLTE	MYSM1	786	Q5VVJ2